Dupixent subcutaneous injection 300 mg pen

Dupixent subcutaneous injection 300 mg pen, from Sanofi, contains dupilumab (genetical recombination) and is a biologic medicine for multiple inflammatory conditions. It is used to treat moderate-to-severe atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyps, and other related conditions. This 300mg 2mL 1 kit formulation has a YJ code of 4490405G2020.